机构:
Univ Michigan, Program Cellular & Mol Biol, Sch Med, Ann Arbor, MI 48109 USAUniv Michigan, Program Cellular & Mol Biol, Sch Med, Ann Arbor, MI 48109 USA
Bennett, Shauna M.
[1
]
Broekema, Nicole M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USAUniv Michigan, Program Cellular & Mol Biol, Sch Med, Ann Arbor, MI 48109 USA
Broekema, Nicole M.
[2
]
Imperiale, Michael J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan, Program Cellular & Mol Biol, Sch Med, Ann Arbor, MI 48109 USA
Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA
Univ Michigan, Ctr Comprehens Canc, Sch Med, Ann Arbor, MI 48109 USAUniv Michigan, Program Cellular & Mol Biol, Sch Med, Ann Arbor, MI 48109 USA
Imperiale, Michael J.
[1
,2
,3
]
机构:
[1] Univ Michigan, Program Cellular & Mol Biol, Sch Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Comprehens Canc, Sch Med, Ann Arbor, MI 48109 USA
BK polyomavirus (BKPyV) is a small double-stranded DNA virus that is an emerging pathogen in immunocompromised individuals. BKPyV is widespread in the general population, but primarily causes disease when immune suppression leads to reactivation of latent virus. Polyomavirus-associated nephropathy and hemorrhagic cystitis in renal and bone marrow transplant patients, respectively, are the most common diseases associated with BKPyV reactivation and lytic infection. In this review, we discuss the clinical relevance, effects on the host, virus life cycle, and current treatment protocols. (C) 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.